Skip to main content

Table 2 Clinical features and test results suggestive of latent tuberculosis infection in patients with chronic inflammatory arthritis after exposure to TNFα inhibitors

From: Performance of 4 methods for screening of latent tuberculosis infection in patients with chronic inflammatory arthritis under TNFα inhibitors: a 24-month prospective study

LTBI parameters

JIA (n = 20)

RA (n = 40)

AS (n = 35)

PsA (n = 7)

p value

BCG scar

20 (100%)

19 (47.5%)

27 (77.1%)

5 (71.4%)

0.001

Chest X-ray abnormalities

0

2 (5%)

1 (2.8%)

0

0.834

Positive TB epidemiology

0

7 (17.5%)

4 (11.4%)

1 (14.3%)

0.214

Positive TST

0

12 (30%)

13 (37.1%)

3 (42.9%)

0.017

Positive IGRA

     

 T-SPOT.TB

1 (5%)

14 (35%)

10 (28.6%)

2 (28.6%)

0.097

 Quantiferon

1 (5%)

9 (22.5%)

7 (20%)

2 (28.6%)

0.277

  1. JIA, juvenile idiopathic arthritis; RA, rheumatoid arthritis; AS, ankylosing spondylitis; PsA, psoriatic arthritis; BCG, Bacillus Calmette-Guérin, TB, tuberculosis, LTBI, latent tuberculosis infection; TST, tuberculin skin test; IGRA, interferon gamma release assay; T-SPOT.TB, Elispot